The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.
The latest from CDMOs, CMOs, and suppliers featuring Catalent, Lonza, Aceto, Abzena, and Ascendia Pharmaceuticals.
Chemicals/Chemical API Manufacturing
Aceto Acquires A&CAceto, a provider of specialty materials for life sciences and advanced...
Thermo Fisher Scientific has agreed to acquire PPD, a contract research organization, for $17.4 billion plus the assumption of approximately $3.5 billion of net debt.
PPD provides a range of clinical research and laboratory services for drug...
Resilience, a recently launched manufacturing and technology company for biologics and advanced therapies, has acquired Ology Bioservices, an Alachua, Florida-based biologics CDMO.
Resilience was launched in November 2020 with initial capital of...
The latest from CDMOs/CMOs and suppliers in COVID-19 projects featuring Catalent, Celonic, and Exothera.
Biologics Manufacturing
Celonic, CureVac in Mfg Pact for COVID-19 VaccineCelonic, a Basel, Switzerland-headquartered CDMO of advanced therapy...
The latest from CDMOs, CMOs, and suppliers featuring Fujifilm Diosynth Biotechnologies, Sterling Pharma Solutions, ADC Bio, Bora Pharmaceuticals, Crystec, and Cryoport.
Biologics Manufacturing
Fujifilm Diosynth Breaks Ground for Microbial...
Nitto Denko Corporation, an Osaka, Japan-based manufacturer of industrial and life science products, will invest approximately JPY 25 billion ($255 million) in its Milford, Massachusetts subsidiary, Nitto Denko Avecia, and other business to...
Resilience, a recently launched manufacturing and technology company for biologics and advanced therapies, has acquired two commercial manufacturing facilities in North America, including a facility from Sanofi.
Resilence was launched in November...
The latest from CDMOs, CMOs, and suppliers featuring Lonza, NextPharma, Catalent, Piramal Pharma Solutions, Asymchem, Aji Bio-Pharma, Rentschler Biopharma, and others.
Chemicals/Chemical API Manufacturing
Asymchem Expands Oligonucleotides Mfg...
Fujifilm Diosynth Biotechnologies, a biologics CDMO and a subsidiary of Fujifilm Corporation, has selected Holly Springs, North Carolina as the location for its new JPY 200 billion ($1.9-billion) large-scale cell-culture biomanufacturing site....
The latest from CDMOs, CMOs, and suppliers featuring LabVantage Solutions, Raybow, Thermo Fisher Scientific, Wacker, and JSR Life Sciences.
Chemical/Chemical API Manufacturing
Raybow To Expand Operations with $15.8 M InvestmentRaybow USA, the...
The Board of Directors of Alcami, a CDMO of drug products and provider of analytical testing services, has appointed Patrick D. Walsh as Chairman and Chief Executive Officer (CEO), effective immediately (as reported on March 18, 2021). Mr. Walsh...
The latest from CDMOs, CMOs, and suppliers featuring MilliporeSigma, Aceto, PCI Pharma Services, Maravai LifeSciences, and Univercells.
Biologics Manufacturing
MilliporeSigma Invests $30 M To Add Single-Use Assembly Production Line MilliporeSigma...
The latest from CDMOs/CMOs and suppliers in COVID-19 projects featuring Lonza and BioCentriq.
Biologics Manufacturing
Lonza, Altimmune Expand Mfg Pact for COVID-19 Vaccine Lonza and Altimmune, a Gaithersburg, Maryland-based clinical-stage...
WuXi Biologics, a contract biologics manufacturer, is increasing its position in China with two separate deals: an agreement to acquire Pfizer’s biologics drug-substance and drug-product manufacturing facilities in Hangzhou, China, and a...
Fujifilm Corporation has agreed to invest JYP 100 million ($918 million) into Cuorips, a Tokyo-based start-up company developing regenerative medicines for treating heart failure, through underwriting a third-party allocation of shares. It also...
